Navigation Links
Pennsaid(R) Phase 3 study results to be published in leading international PAIN journal
Date:4/23/2009

request to review the side effect profile of Pennsaid if combined with an oral NSAID. This combination showed no increased incidence of the usual systemic side effects, just the expected additive profiles of Pennsaid alone plus oral diclofenac alone.

Dry skin was the most common adverse event with Pennsaid use. Fewer digestive system adverse events and laboratory abnormalities (decreased hemoglobin and increased AST, ALT and creatinine) were observed with Pennsaid as compared to oral diclofenac.

About Nuvo Research Inc.

Nuvo is focused on the research and development of drug products delivered to and through the skin using its topical and transdermal drug delivery technologies. Nuvo's lead product is Pennsaid(R), a topical non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis. Nuvo intends to leverage its skin-penetrating technologies to create a portfolio of topical and transdermal products targeting a variety of indications.

Nuvo Research Inc. is a publicly traded, Canadian pharmaceutical company headquartered in Mississauga, Ontario, with manufacturing facilities in Varennes, Quebec and Wanzleben, Germany and a research and development Center in San Diego California. For more information, please visit.www.nuvoresearch.com

These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but caution that these assumptions regarding future events, many of which are beyond the control of the Company, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies
2. FDA Accepts Nuvos Resubmission For Pennsaid(R)
3. Ovation further advances development pipeline with new phase III epilepsy study
4. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
5. Mannatech Launches Phase One of New Sales and Training Tools
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Manic phase of bipolar disorder benefits from breast cancer medication
8. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
9. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
10. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
11. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 "After ... people who don’t stand very often, I decided that there ... longer periods during the day," said a concerned inventor from ... can’t stand for long periods. It builds endurance and keeps ... promote better health. Easy to use and producible in design ...
(Date:8/29/2014)... New Delhi, India (PRWEB) August 29, 2014 ... marketing firm, has recently launched a new service named ... is a research based service. Before tailoring the service, ... being provided by other companies. The company has done ... must be impeccable and able to deliver outstanding results ...
(Date:8/29/2014)... basic life support (BLS) videos available on YouTube ... guidelines, according to a new study published in ... the Australasian College for Emergency Medicine (ACEM). ... arrest are known to improve survival for,victims. , ... together the study, which reviewed educational videos from ...
(Date:8/29/2014)... has caused disease outbreaks across the Arabian Peninsula and ... has claimed the lives of several hundred people since ... have been puzzled over how easily the pathogen spreads ... led by virologists from the University of Bonn have ... the rate of human transmission is low. Still, a ...
(Date:8/29/2014)... 2014 The Fresh Diet, America’s premier ... new Fresh Vegetarian meal plan. Originating from The Fresh ... new menu is designed to satisfy customers seeking a ... , Responding to the growing demand by customers ... dollar market (Forbes) with 14% of Americans identifying vegetarian ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Launches a New Web Design Service 2Health News:MERS: Low transmissibility, dangerous illness 2Health News:MERS: Low transmissibility, dangerous illness 3Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3
... area health care organizations agree that today,s tough ... organizations provided tips for Ohioans to stay healthy. , ... Columbus, Central Ohio Diabetes Association, Columbus Dietetic Association, Lilly ... Ohio Association of Free Clinics, Ohio Department of Health ...
... found parents still show a gender bias, however , MONDAY, ... join a sports team or be active if their parents ... 681 parents and 433 fourth- and fifth-grade students at 12 ... both boys and girls -- of parents who valued high-intensity ...
... and Company (NYSE: LLY ) announced today ... and Drug Administration (FDA) for ALIMTA(R) (pemetrexed for injection). ... maintenance therapy for locally advanced or metastatic non-small cell ... histology whose disease has not progressed after four cycles ...
... 6 DynaVox Systems LLC, the world,s ... with speech, language and learning disabilities, today announced that ... acquisition reinforces DynaVox,s commitment to providing the appropriate communication ... the company,s position as the market leader in the ...
... RATON, Fla., July 6 After 25 years in the ... other fitness classes, Dale Buchanan, a Washington, DC native, has ... it to South Florida in his new studio located in ... combination of High Intensity Fitness Training and T,ai Chi. , ...
... Coapt Systems, Inc. ( www.coaptsystems.com ) ... acid based dermal filler for the treatment of facial ... Hydrelle is the first FDA-approved hyaluronic acid filler ... Proven safe and effective, Hydrelle is also a ...
Cached Medicine News:Health News:Top 10 Tips for Staying Healthy When Money is Tight 2Health News:Top 10 Tips for Staying Healthy When Money is Tight 3Health News:Kids of Parents Who Value Exercise Are More Active 2Health News:Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection) 2Health News:Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection) 3Health News:Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection) 4Health News:Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection) 5Health News:Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection) 6Health News:Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection) 7Health News:DynaVox Systems LLC Merges with Blink Twice 2Health News:DynaVox Systems LLC Merges with Blink Twice 3Health News:Boca Raton, FL Becomes Home of Dale Buchanan's Supreme Ultimate Fitness 2Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 2Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 3Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 4
(Date:8/28/2014)... Japan , Aug. 28, 2014 ... of the post-marketing commitment and submissions of data ... including the United States ... Medicines Agency (EMA) and the Japanese Ministry of ... Pharmaceuticals and Medical Devices Agency (PMDA) for pioglitazone ...
(Date:8/28/2014)... LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ -- ... 2000 by service academy graduates, has published a ... concentrated, three-day Leadership Excellence Course . In September ... Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... , Aug. 28, 2014   Edison ... today announced a worldwide search for product ideas ... senior population.  Promising ideas uncovered through the 6-month ... leading medical device manufacturers and healthcare retailers with ... the lives of individuals age 65 and older. ...
Breaking Medicine Technology:Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... Health Corp. (Nasdaq: WBMD ) today announced that executives of ... Small and Mid Cap Conference on Friday, November 20, 2009 at ... public are invited to listen to a live audio broadcast of ... at www.wbmd.com (in the Investor Relations section). ...
... , NEW HAVEN, Conn., Nov. 17 HistoRx ... image analysis platform based on tissue-based quantitative immunofluorescence, was noted ... Task Force Report on hormone receptor testing in ... being developed for the measurement of ER and PgR in ...
Cached Medicine Technology:AQUA(R) Technology Recognized as 'Promising New Strategy' for Hormone Receptor Testing in Breast Cancer by NCCN Task Force 2
... self-contained work area that will help protect ... bulbs irradiate the work area prior to ... will be amplified. Containment features reduce the ... has acrylic windows for a clear view, ...
Remote Alpha Dock system for the DNA Engine line, allows, Alpha unit to function remotely (requires fan power supply)...
... designed for highthroughput reading of tube racks. Its ... less than one second per rack, making it ... design of the reader allows a rack to ... by robotic arms. An optical safety switch prevents ...
... stainless steel work surface. ... vibration to protect operator, ... vibration-producing equipment from the ... allows for multiple vibration-free ...
Medicine Products: